Cargando…
Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes
Defining permissive and non-permissive mismatches for transplantation is a demanding challenge. Single mismatches at amino acid (AA) position 156 of human leucocyte antigen (HLA) class I have been described to alter the peptide motif, repertoire, or mode of peptide loading through differential inter...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799800/ https://www.ncbi.nlm.nih.gov/pubmed/26758079 http://dx.doi.org/10.1007/s00251-015-0896-4 |
_version_ | 1782422398274895872 |
---|---|
author | Manandhar, Trishna Kunze-Schumacher, Heike Huyton, Trevor Celik, Alexander A. Blasczyk, Rainer Bade-Doeding, Christina |
author_facet | Manandhar, Trishna Kunze-Schumacher, Heike Huyton, Trevor Celik, Alexander A. Blasczyk, Rainer Bade-Doeding, Christina |
author_sort | Manandhar, Trishna |
collection | PubMed |
description | Defining permissive and non-permissive mismatches for transplantation is a demanding challenge. Single mismatches at amino acid (AA) position 156 of human leucocyte antigen (HLA) class I have been described to alter the peptide motif, repertoire, or mode of peptide loading through differential interaction with the peptide-loading complex. Hence, a single mismatch can tip the balance and trigger an immunological reaction. HLA-B*35 subtypes have been described to evade the loading complex, 156 mismatch distinguishing B*35:01 and B*35:08 changes the binding groove sufficiently to alter the sequence features of the selected peptide repertoire. To understand the functional influences of residue 156 in B*35 variants, we analyzed the peptide binding profiles of HLA-B*35:01(156Leu), B*35:08(156Arg) and B*35:62(156Trp). The glycoprotein tapasin represents a target for immune evasions and functions within the multimeric peptide-loading complex to stabilize empty class I molecules and promote acquisition of high-affinity peptides. All three B*35 subtypes showed a tapasin-independent mode of peptide acquisition. HLA-B*35-restricted peptides of low- and high-binding affinities were recovered in the presence and absence of tapasin and subsequently sequenced utilizing mass spectrometry. The peptides derived from B*35 variants differ substantially in their features dependent on their mode of recruitment; all peptides were preferentially anchored by Pro at p2 and Tyr, Phe, Leu, or Lys at pΩ. However, the Trp at residue 156 altered the p2 motif to an Ala and restricted the pΩ to a Trp. Our results highlight the importance of understanding the impact of key micropolymorphism and how a single AA mismatch orchestrates the neighboring AAs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00251-015-0896-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4799800 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-47998002016-04-06 Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes Manandhar, Trishna Kunze-Schumacher, Heike Huyton, Trevor Celik, Alexander A. Blasczyk, Rainer Bade-Doeding, Christina Immunogenetics Original Article Defining permissive and non-permissive mismatches for transplantation is a demanding challenge. Single mismatches at amino acid (AA) position 156 of human leucocyte antigen (HLA) class I have been described to alter the peptide motif, repertoire, or mode of peptide loading through differential interaction with the peptide-loading complex. Hence, a single mismatch can tip the balance and trigger an immunological reaction. HLA-B*35 subtypes have been described to evade the loading complex, 156 mismatch distinguishing B*35:01 and B*35:08 changes the binding groove sufficiently to alter the sequence features of the selected peptide repertoire. To understand the functional influences of residue 156 in B*35 variants, we analyzed the peptide binding profiles of HLA-B*35:01(156Leu), B*35:08(156Arg) and B*35:62(156Trp). The glycoprotein tapasin represents a target for immune evasions and functions within the multimeric peptide-loading complex to stabilize empty class I molecules and promote acquisition of high-affinity peptides. All three B*35 subtypes showed a tapasin-independent mode of peptide acquisition. HLA-B*35-restricted peptides of low- and high-binding affinities were recovered in the presence and absence of tapasin and subsequently sequenced utilizing mass spectrometry. The peptides derived from B*35 variants differ substantially in their features dependent on their mode of recruitment; all peptides were preferentially anchored by Pro at p2 and Tyr, Phe, Leu, or Lys at pΩ. However, the Trp at residue 156 altered the p2 motif to an Ala and restricted the pΩ to a Trp. Our results highlight the importance of understanding the impact of key micropolymorphism and how a single AA mismatch orchestrates the neighboring AAs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00251-015-0896-4) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-01-12 2016 /pmc/articles/PMC4799800/ /pubmed/26758079 http://dx.doi.org/10.1007/s00251-015-0896-4 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Manandhar, Trishna Kunze-Schumacher, Heike Huyton, Trevor Celik, Alexander A. Blasczyk, Rainer Bade-Doeding, Christina Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes |
title | Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes |
title_full | Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes |
title_fullStr | Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes |
title_full_unstemmed | Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes |
title_short | Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes |
title_sort | understanding the obstacle of incompatibility at residue 156 within hla-b*35 subtypes |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799800/ https://www.ncbi.nlm.nih.gov/pubmed/26758079 http://dx.doi.org/10.1007/s00251-015-0896-4 |
work_keys_str_mv | AT manandhartrishna understandingtheobstacleofincompatibilityatresidue156withinhlab35subtypes AT kunzeschumacherheike understandingtheobstacleofincompatibilityatresidue156withinhlab35subtypes AT huytontrevor understandingtheobstacleofincompatibilityatresidue156withinhlab35subtypes AT celikalexandera understandingtheobstacleofincompatibilityatresidue156withinhlab35subtypes AT blasczykrainer understandingtheobstacleofincompatibilityatresidue156withinhlab35subtypes AT badedoedingchristina understandingtheobstacleofincompatibilityatresidue156withinhlab35subtypes |